Amsterdam’s NeuroReality and its cognitive rehab tool “Koji’s Quest” gets acquired by US-based XRHealth

XRHealth, a US-based Extended Reality therapy platform for healthcare, has acquired Amsterdam’s NeuroReality, including its flagship cognitive rehabilitation product “Koji’s Quest”, to strengthen its position in the extended reality (XR) therapeutic market.

The development adds to XRHealth’s growing portfolio, which includes a recent acquisition of Amelia Virtual Care, and enhances its offerings for physical, emotional, and cognitive rehabilitation through XR technology.

Eran Orr, XRHealth’s CEO, emphasised that the acquisition aligns with the company’s mission to create a comprehensive platform for patients and clinicians, combining AI-powered XR technology with clinical expertise.

XRHealth aims to transform healthcare by offering immersive, accessible digital health solutions across various therapeutic areas.

This development comes three months after NeuroReality announced that the company was winding down its business due to “unforeseen complications”. However, NeuroReality founder Faviola Dadis was optimistic about the future. Dadis mentions in a LinkedIn post, “Unforeseen complications beyond our control have forced us to make this difficult choice and we are looking into new ways to reboot and level up.”

Cognitive training in virtual reality

NeuroReality aims to transform cognitive training and rehabilitation through a blend of scientific research and gamification, aiming to make the process effective, engaging, and accessible for individuals with cognitive challenges. 

Its virtual reality (VR) games target key cognitive skills such as calculation, attention, memory, visuospatial abilities, executive functions, and reaction time.

Each game adapts to the user’s abilities, providing an enjoyable experience for individuals at all levels of cognitive function, including those with severe impairments. NeuroReality’s flagship product, “Koji’s Quest”, exemplifies this user-focused approach.

In collaboration with VU University Amsterdam and the Game Cella Lab, NeuroReality is conducting research that highlights the benefits of its VR solutions for stroke survivors.

Aim of the acquisition

With this acquisition, XRHealth enhances its tools for healthcare providers, offering more interactive ways to support patient recovery and improve health outcomes using VR and XR technology.

The inclusion of “Koji’s Quest” reinforces XRHealth’s dedication to improving accessibility and effectiveness in XR therapies, fostering advancements in digital healthcare.

Eran Orr, CEO of XRHealth, says, “The acquisition of NeuroReality and its flagship product, Koji’s Quest, represents another leap forward in our mission to provide the most comprehensive XR therapeutic platform available.”

“We are focused on creating a transformative experience for patients and clinicians alike, and Koji’s Quest will allow us to offer an even richer, more engaging set of tools for therapy and rehabilitation.”

Brief about XRHealth

XRHealth, a provider of AI-powered healthcare solutions, uses extended reality (XR) technology to improve patient care and rehabilitation. Its platform supports applications like physical therapy, cognitive rehabilitation, pain management, and mental health. 

The company operates clinics and collaborates with healthcare organisations worldwide, integrating XR therapies into diverse clinical settings. 

After acquiring Amelia Virtual Care, XRHealth expanded its mental health offerings, enhancing the accessibility and effectiveness of digital healthcare. Combining AI insights with clinical expertise, XRHealth aims to drive innovation in global healthcare.